Avidity Biosciences Inc. (RNA)
27.82
0.77 (2.85%)
At close: Jan 15, 2025, 1:44 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -3.11 | -6.85 | -8.39 | -12.57 | -33.28 | -49.39 |
| PS Ratio | 69.12 | 125.49 | 105.59 | 81.46 | 461.00 | 1.56K |
| PB Ratio | 1.32 | 2.00 | 2.58 | 1.81 | -16.36 | -14.33 |
| P/FCF Ratio | -5.36 | -8.32 | -9.99 | -14.47 | 474.08 | -60.74 |
| P/OCF Ratio | -5.55 | -8.49 | -10.39 | -14.89 | 429.34 | -61.05 |
| OCF/S Ratio | -12.45 | -14.77 | -10.17 | -5.47 | 1.07 | -25.47 |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.00 | -0.08 | -0.25 |
| Quick Ratio | 7.58 | 12.00 | 13.89 | 22.82 | 9.35 | 0.70 |
| Current Ratio | 7.58 | 12.00 | 13.86 | 22.74 | 9.35 | 0.70 |
| Asset Turnover | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.10 |
| Interest Coverage | n/a | n/a | n/a | -211.85 | -2.35 | -14.62 |
| Return on Equity (ROE) | -0.42 | -0.29 | -0.31 | -0.14 | 0.49 | 0.29 |
| Return on Assets (ROA) | -0.34 | -0.26 | -0.27 | -0.13 | -0.33 | -3 |
| Return on Capital (ROIC) | -0.43 | -0.3 | -0.3 | -0.14 | -0.2 | 16.56 |
| Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | -0.00 | n/a |
| Gross Profit Margin | 78.02% | 84.96% | 93.15% | -454.03% | -526.95% | -2.13K% |
| Net Profit Margin | -2.22K% | -1.83K% | -1.26K% | -648.03% | -1.39K% | -3.15K% |
| Pretax Profit Margin | -2.22K% | -1.89K% | -1.27K% | -653.53% | -1.07K% | -2.96K% |
| Operating Profit Margin | -2.46K% | -1.94K% | -1.27K% | -652.38% | -747.39% | -2.77K% |
| FCF Margin | -1.29K% | -1.51K% | -1.06K% | -562.97% | 97.24% | -2.56K% |
| EBITDA Margin | -2.44K% | -1.92K% | -1.26K% | -644.95% | -722.29% | -2.67K% |